SCHEMBL21801799

SCHEMBL21801799

COC1=C(N)C(=O)c2nc(-c3cccc(OC(F)(F)F)c3)ccc2C1=O

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NSD2 O96028 1/20 0.51
G6PD P11413 1/20 0.51
DNMT1 P26358 1/20 0.51
XDH P47989 1/20 0.50
ADORA1 P30542 3/20 0.44
ADORA2A P29274 2/20 0.44
UCHL3 P15374 1/20 0.44
S100A4 P26447 1/20 0.43
ATR Q13535 1/20 0.43
FNTA P49354 1/20 0.42
FNTB P49356 1/20 0.42
DYRK1A Q13627 2/20 0.42
CTSS P25774 1/20 0.41
CTSK P43235 1/20 0.41
PDE10A Q9Y233 1/20 0.41
KDM4E B2RXH2 1/20 0.40
MEN1 O00255 1/20 0.40
NPC1 O15118 1/20 0.40
LMNA P02545 1/20 0.40
POLB P06746 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21801756 0.87 NSD2 (0.51) NSD2G6PDDNMT1XDHADORA1
SCHEMBL21801766 0.83 NSD2 (0.59) NSD2G6PDDNMT1ADORA1ADORA2A
SCHEMBL21801902 0.82 XDH (0.41) XDHADORA1ADORA2AATRDYRK1A
SCHEMBL21801720 0.80 TDP2 (0.48) NSD2XDHADORA1ADORA2AATR
SCHEMBL21801808 0.80 XDH (0.55) XDHADORA1ADORA2AATRDYRK1A
SCHEMBL21801780 0.77 NSD2 (0.52) NSD2G6PDDNMT1ADORA1ADORA2A
SCHEMBL21801735 0.76 NSD2 (0.53) NSD2G6PDDNMT1UCHL3S100A4
SCHEMBL21801953 0.74 NSD2 (0.60) NSD2G6PDDNMT1ADORA1ADORA2A
SCHEMBL21801758 0.73 NSD2 (0.59) NSD2G6PDDNMT1UCHL3S100A4
SCHEMBL21801909 0.72 NSD2 (0.52) NSD2G6PDDNMT1UCHL3S100A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020055192-A2 PREPARATION METHOD FOR QUINOLINE-5, 8-DIONE DERIVATIVE WHICH IS TGASE 2 INHIBITOR 재단법인 대구경북첨단의료산업진흥재단 2020-03-19 WO disclosed